238. Deputy Clare Daly asked the Minister for Health his plans to review the licensing conditions used by the HPRA in regard to medical devices in view of the extremely severe side effects of transvaginal mesh, one brand of which (details supplied) was brought to market following a trial in only 31 women and in which the mesh failed in 30% of subjects. [4883/18]

Summary

238. Deputy Clare Daly asked the Minister for Health his plans to review the licensing conditions used by the HPRA in regard to medical devices in view of the extremely severe side effects of transvaginal mesh, one brand of which (details supplied) was brought to market following a trial in only 31 women and in which the mesh failed in 30% of subjects. [4883/18]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Regulation

  xml · EN · 31 January 2018

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.